×

Intellectual Property Patents

  • Sept 8- Allergan Plc will transfer to the Saint Regis Mohawk Tribe the rights to its blockbuster Restasis dry-eye treatment, the drugmaker said on Friday, in an unusual deal to protect it from patent challenges. The tribe, which has sovereign immunity from such challenges, will receive a one-time payment of $13.75 million and annual royalties of around $15...

  • Brent Saunders, president and CEO of Allergan.

    Allergan transferred patents for its eye drug Restasis to the Saint Regis Mohawk Tribe, which then granted it back an exclusive license.

  • Sept 8- Allergan Plc will transfer to the Saint Regis Mohawk Tribe rights to its blockbuster Restasis dry-eye treatment, the drugmaker said on Friday, in an unusual deal to protect it from patent challenges. The tribe, which has sovereign immunity from such challenges, will receive a one-time payment of $13.75 million and annual royalties of around $15 million...

  • Sept 5- A federal judge in Delaware on Tuesday invalidated patents held by Mallinckrodt Pharmaceuticals on its Inomax respiratory treatment system. Mallinckrodt noted it had regulatory exclusivity for the treatment until October 2018. Mallinckrodt shares have been targeted by short sellers, with 18.6 percent of the shares outstanding held as short...

  • Sept 1- Shares in London- listed Indivior plunged 40 percent after the drugmaker said a U.S. court ruling could clear the way for a generic rival to its treatment for opioid addiction that generates 80 percent of its revenues. Indivior said the Delaware District Court ruling meant it would not be able to rely on patents to prevent Indian firm Dr.Reddy' s from making...

  • Sept 1- Shares in Indivior plunged 40 percent on Friday after it said a U.S. court ruling could lead to a generic rival to its treatment for opioid addiction that generates 80 percent of the London- listed drug maker's revenues. Indivior has said it would not be able to rely on patents to prevent Indian firm Dr.Reddy' s from making and marketing a generic alternative...

  • Reddy's from making and marketing a generic alternative to Suboxone Film in the United States, unless the court's ruling was reversed on appeal. The firm said the average market share of Suboxone Film in the United States was 61 percent in 2016, and accounted for 80 percent of Indivior's total revenues last year. Shares in Indivior, which was spun off from...

  • Crocs.

    The U.S. Patent and Trademark Office has ruled in favor of USA Dawgs, which sells shoes with a similar design.

  • The Nintendo Switch gaming console

    Video game developer Nintendo is being sued by Gamevice, who claims the Nintendo Switch controllers infringe on a product patent.

  • WASHINGTON/ SAN FRANCISCO, Aug 8- U.S. trade officials have agreed to investigate Qualcomm Inc's allegations that Apple Inc infringed on patents with its iPhone 7 and other devices, the U.S. International Trade Commission said on Tuesday. "We look forward to the ITCs expeditious investigation of Apples ongoing infringement of our intellectual property and the...

  • WASHINGTON/ SAN FRANCISCO, Aug 8- U.S. trade officials have agreed to investigate Qualcomm Inc's allegations that Apple Inc infringed on patents with its iPhone7 and other devices, the U.S. International Trade Commission said on Tuesday. The ITC will make its decision "at the earliest practicable time" and will set a target date for completing its investigation...

  • WASHINGTON, Aug 8- U.S. trade officials have agreed to investigate Qualcomm Inc's allegations that Apple Inc infringed on patents with its iPhone7 and other devices, the U.S. International Trade Commission said on Tuesday. The ITC will make its decision "at the earliest practicable time" and will set a target date for completing its investigation within the next...

  • WASHINGTON, Aug 8- U.S. trade officials have agreed to investigate Qualcomm Inc's allegations that Apple Inc infringed on patents with its iPhone7 and other devices, the U.S. International Trade Commission said in a statement on Tuesday.

  • 'Tricky dance' between US and China on trade and North Korea: Michael Froman

    Michael Froman, former U.S. trade representative, provides insight to the balancing act the Trump administration must traverse when dealing with China on trade talks and North Korea's increasing aggression.

  • Steve Mollenkopf, CEO of Qualcomm

    "Squawk on the Street's" David Faber talks to Qualcomm CEO Steve Mollenkopf about its battle with Apple.

  • CNBC IQ 100 up 20% last year. These companies took the top spots...

    David Martin, M-CAM CEO, breaks down the data on which companies scored big by using augmented intelligence to drive tech innovation.

  • *Due on Thursday, July 27 at 0500 GMT. HELSINKI, July 24- Telecoms gear maker Nokia is likely to see a boost to quarterly earnings on Thursday from a recent patent licensing deal with Apple that offsets weak demand in its main equipment business from network operators. The average forecast for Nokia's second-quarter operating profit is 447 million euros, up 35...

  • *Due on Thursday, July 27 at 0500 GMT. HELSINKI, July 24- Telecoms gear maker Nokia is likely to see a boost to quarterly earnings on Thursday from a recent patent licensing deal with Apple that offsets weak demand in its main equipment business from network operators. The average forecast for Nokia's second-quarter operating profit is 390 million euros, up 35...

  • July 17- A U.S. appeals court ruled on Monday that a patent on Takeda Pharmaceutical Co Ltd's cancer treatment Velcade is valid, pushing back the date when generic drug makers including Teva Pharmaceutical Industries Ltd and Mylan NV will be allowed to launch lower-cost versions of the drug in the United States. The U.S. Court of Appeals for the Federal Circuit...

  • July 7- Eli Lilly and Co won a years-long patent dispute with Actavis on Friday after the UK Supreme Court ruled that the generic drugmaker's versions of Lilly's top-selling cancer drug Alimta directly infringe on certain Lilly patents in Britain, France, Italy and Spain. The court's key conclusions confirm that the Alimta vitamin regimen patent would be...